by Maria Zannes | Jun 15, 2023 | Press Releases
SAN ANTONIO, Texas (June 15, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for early-stage cancer detection and broad-spectrum cancer therapeutics, will present the poster “Vitamin B12 deprivation does not...
by Maria Zannes | Jun 12, 2023 | Events
bioAffinity Technologies President and CEO Maria Zannes is attending the National Association of Veterans’ Research and Education Foundations’ (NAVREF) quarterly meeting of industry partners in Portland, OR, June 12-13. NAVREF is a non-profit organization dedicated to...
by Maria Zannes | Jun 6, 2023 | Events
bioAffinity Technologies, Inc. held its 2023 Annual Meeting of Stockholders on June 6, 2023, both in person at the Company’s principal office in San Antonio, TX, and virtually via a live webcast on June 6, 2023. Shareholders were entitled to cast one vote per share of...
by Maria Zannes | May 22, 2023 | Press Releases
SAN ANTONIO, Texas (May 22, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today will present the poster “Development of...
by Maria Zannes | May 15, 2023 | Press Releases
SAN ANTONIO, Texas (May 15, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three...
